21688 results for «»

Filter By

21688 results

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

Residual Leaks Post Left Atrial Appendage Occlusion

03 Apr 2022

Michele Pighi provides his take on the National Cardiovascular LAAO Registry that analyzed data from 51,333 patients who underwent LAAO procedures with the WATCHMAN device between 2016-2019, as part of the College's NCDR registries.

M. Pighi

Author

Michele Pighi
Residual Leaks Post Left Atrial Appendage Occlusion

One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation

22 Mar 2022

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

Alessandro Sticchi

Author

Alessandro Sticchi
Luigi Biasco

Author

Luigi Biasco
One-year Results of the Clasp TR Study: Transcatheter Treatment of Tricuspid Regurgitation

Complete revascularisation: from defining PCI strategy to PCI optimisation

22 Dec 2021 – From GulfPCR-GIM 2021

In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.

Complete revascularisation:

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa
A Randomized ADAPT-TAVR Trial: Edoxaban Vs DAPT For Valve Thrombosis and Cerebral Thromboembolism After TAVR

GHATI: Improving STEMI management internationally

05 Apr 2022

Mirvat Alasnag interviews Cesar Herrera, Hadley Wilson & Benny Levenson, principal investigators of the GHATI trial: A two-year report of 4,015 patients enrolled in the American College of Cardiology - Global Heart Attack Treatment Initiative.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
GHATI: Improving STEMI management internationally

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

IMPELLA protected PCI and intravascular lithotripsy in a calcified degenerated saphenous vein graft

27 Jan 2022

Find out more about a 77-year-old male patient with hypertension without good BP control, dyslipidaemia, Type II-DM, ex-smoker, who had triple CABG in 2006, EF 60% in 2017, and presented with dyspnea. 

Author

Flavio Luciano Ribichini
Gabriele Pesarini

Author

Gabriele Pesarini
IMPELLA protected PCI and intravascular lithotripsy in a calcified degenerated saphenous vein graft

How should I treat? - TAVI in small anatomy with significant LVOT calcification

20 Jan 2022

An 89-year-old man was referred for treatment of severe symptomatic aortic stenosis. This case describes the decision-making in performing TAVI in a patient with twin challenges of small annulus and significant LVOT calcification.

Author

Dan Blackman
Cunnington Michael

Author

Cunnington Michael
Chris Malkin

Author

Christopher Malkin
How should I treat? - TAVI in small anatomy with significant LVOT calcification

Approach to calcified lesions and role of plaque modification and intravascular imaging to obtain optimal PCI - Session with LIVE case

15 Dec 2021 – From GulfPCR-GIM 2021

Watch the case of a 55-year-old male patient who is a diabetic on insulin and hypotensive, who initially presented with NSTEMI and 3-vessel disease but declined CABG before being readmitted with unstable angina.

Approach to calcified lesions and role of plaque modification and intravascular imaging to obtain optimal PCI

Defining percutaneous coronary intervention complexity and risk: an analysis of the UK BCIS Database 2006-2016

04 Jan 2022

A multiple logistic regression model was developed to identify variables associated with in-hospital MACCE and to construct a CHIP score. The cumulative effect of this score on patient outcomes was examined.

Reviewer

Salvatore Brugaletta
Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS Database 2006-2016

Top 10 most cited 2021 articles in the Transcatheter Tricuspid field

11 Jan 2022

A. Sticchi and J. Curio provide you with a summary of the studies that highlighted 2021 in the field of transcatheter tricuspid intervention: TRILUMINATE, CLASP TR EFS, EVOQUE TTVR, TRI-REPAIR, and more.

A. Sticchi and J. Curio

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

12 Jan 2022

Cunnington Michael

Leeds, United Kingdom

Cunnington Michael

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results

21 Jan 2022

The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.

Luigi Biasco

Reviewer

Luigi Biasco
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results

Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR

26 Jan 2022

Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR

SMT announces positive results of Hydra™ Transcatheter Aortic Heart Valve published in JACC: Cardiovascular Interventions

20 Jan 2022

Didn’t find what you were looking for?